HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael Rugaard Jensen Selected Research
Michael Rugaard Jensen Research Topics
Disease
9
Neoplasms (Cancer)
01/2019 - 04/2003
3
Breast Neoplasms (Breast Cancer)
04/2010 - 01/2008
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2017
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2013
1
Melanoma (Melanoma, Malignant)
04/2010
1
Pathologic Constriction (Stenosis)
03/2010
1
Thrombosis (Thrombus)
03/2010
1
Coronary Artery Disease (Coronary Atherosclerosis)
03/2010
1
Atherosclerotic Plaque (Atheroma)
03/2010
1
Carcinogenesis
01/2008
Drug/Important Bio-Agent (IBA)
7
Proteins (Proteins, Gene)
FDA Link
01/2017 - 07/2006
2
Pharmaceutical Preparations
IBA
11/2015 - 01/2008
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
06/2013 - 01/2008
2
5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamide
IBA
06/2013 - 01/2008
2
Molecular Chaperones (Chaperone, Molecular)
IBA
11/2012 - 08/2009
1
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
01/2017
1
Proto-Oncogene Proteins c-mdm2
IBA
01/2017
1
Tumor Suppressor Protein p53
IBA
01/2017
1
siremadlin
IBA
01/2017
1
ErbB Receptors (EGF Receptor)
IBA
06/2013
1
Tyrosine Kinase Inhibitors
IBA
06/2013
1
Biological Products
IBA
06/2013
1
NVP-BEP800
IBA
04/2010
1
Oxygen (Dioxygen)
IBA
03/2010
1
Biomarkers (Surrogate Marker)
IBA
02/2010
1
Diethylnitrosamine (N-Nitrosodiethylamine)
IBA
04/2003
1
Cyclins
IBA
04/2003
1
Cyclin G1
IBA
04/2003
Therapy/Procedure
4
Therapeutics
01/2019 - 03/2010
1
Oral Administration
04/2010
1
Stents
03/2010
1
Drug-Eluting Stents
03/2010
1
Aftercare (After-Treatment)
04/2003